Nexalis Therapeutics (ASX:NX1): Healthcare Penny Stock Rises as Biotech Watchers Take Notice

• Nexalis Therapeutics (NX1) is a small ASX healthcare and biotech-focused company that has reportedly drawn attention from biotech watchers.

Sonal Goyal | 01 July 2026

Invion (ASX:IVX): Can This Biotech Micro-Cap Reignite Investor Interest?

• Invion (IVX) is a clinical-stage ASX biotech micro-cap, meaning its value rests on research progress rather than current earnings.

Sonal Goyal | 01 July 2026

• The company has historically been associated with hemp-derived and natural products.

Sonal Goyal | 01 July 2026

• Global Health (GLH) provides digital health and clinical software, sitting on the healthcare-technology theme.

Sonal Goyal | 01 July 2026

• Cynata Therapeutics (CYP) is a clinical-stage regenerative medicine developer built around a scalable cell-manufacturing approach.

Sonal Goyal | 01 July 2026

• Cann Group (ASX:CAN) is an ASX-listed medicinal cannabis company operating across cultivation and product supply.

Sonal Goyal | 01 July 2026

• Chimeric Therapeutics (CHM) operates in cell therapy, a frontier area of cancer immunotherapy with binary clinical outcomes.

Sonal Goyal | 01 July 2026

• Paragon Care (ASX: PGC) operates as a diversified healthcare products and services distributor across Australia and the region.

Sonal Goyal | 01 July 2026

• Neuren Pharmaceuticals (ASX: NEU) has rallied on a European regulatory milestone for its Rett syndrome drug trofinetide.

Sonal Goyal | 01 July 2026

• Biome Australia (ASX: BIO) has drawn attention as a health and wellness stock gaining growth-investor interest.

Sonal Goyal | 01 July 2026